Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Dermatology

How Common Is Folliculitis Decalvans and Who Gets It?

At a Glance

Quinquaud folliculitis decalvans is rare, and its exact frequency in the general population is unknown. Specialist clinics report it more often in men and adults in their 30s and 40s, but anyone, including women and younger people, can develop it.

Quinquaud folliculitis decalvans (FD) is a rare, chronic inflammatory condition that causes painful pustules and can permanently damage hair follicles, leading to scarring hair loss. Because it is so rare, there is no exact figure for how many people in the general population have it [1]. Based on data from specialist referral clinics, FD accounts for a very small percentage of all hair loss cases [2]. While anyone can develop FD, larger studies suggest it is more common in men than in women, and patients are typically in their 30s or 40s when evaluated by a specialist [3][4]. However, these demographic patterns are general trends rather than strict rules for diagnosis.

How Common Is FD?

Because FD is uncommon, national health registries often lack a specific coding category for it. Instead, they usually group it together with other forms of primary cicatricial alopecia (scarring hair loss) [1]. As a result, the exact population-wide prevalence (the total number of existing cases in the general public) and incidence (the number of newly diagnosed cases each year) are unknown [1].

Instead, researchers estimate its frequency based on the types of patients who visit specialized referral clinics. These clinic-based percentages should not be interpreted as the lifetime risk for a person in the general population, nor do they represent an individual’s probability of being diagnosed with FD. The percentages vary widely depending on the clinic’s location, the types of patients they see, and the specific group being studied:

  • Among general hair loss (alopecia) diagnoses: In a multinational study of over 2,800 patients at specialist hair clinics, FD accounted for just 2.8% of all hair loss diagnoses [2]. A regional clinic in Mexico found it made up 3.39% of their nearly 1,900 acquired hair loss cases [5].
  • Among scalp disorders: Clinics in Benin and Israel reported that FD made up between 3.3% and 6.6% of patients seen specifically for various scalp or hair disorders [6][7].
  • Among scarring hair loss: If a patient is already diagnosed with a scarring form of hair loss, FD makes up a larger share of those specific cases. Studies of these patients show that FD accounted for roughly 8% to 12% of scarring alopecia diagnoses in particular clinic series [8][9].

Who Typically Gets It?

While anyone can develop FD, researchers have observed a few demographic trends among those who seek treatment at specialty centers.

Sex

In larger, FD-specific studies, the condition shows a male predominance. In two multicenter studies, men made up approximately 60% to 63% of the patients [3][4]. However, women certainly do develop FD, and some smaller clinic studies have reported roughly equal numbers of men and women [10].

Age

Patients in clinical studies are typically in mid-adulthood. The average or median age of patients at the time of their clinic visit ranges between 35 and 40 years old [3][4][10]. It is important to note that this reflects the age at which patients are assessed by specialists, not necessarily the age when their symptoms first began [3]. While symptom onset in childhood or early youth is possible and has been reported, the exact frequency of early onset remains unclear because it is not consistently recorded [11].

Geography and Ethnicity

Available studies have not established a strong ethnic or geographic pattern for FD [8]. It has been reported in diverse populations worldwide, including in patient cohorts from Jamaica, Morocco, Taiwan, and Mexico [12][10][13][5]. Because most information comes from specialized referral centers, comparisons between different ethnicities or regions can be distorted by differences in clinic access, referral patterns, and underrepresentation of certain groups [2].

Understanding the Limitations

When reading about who gets FD, it is crucial to remember the limits of current medical research. Because FD is rare, most studies rely on small groups of patients (often fewer than 100 people) [4][14][10].

These demographic statistics are useful for understanding the disease generally, but they cannot diagnose or exclude FD for an individual. Your age, sex, ethnicity, and country cannot confirm or rule out the condition. If you are female, very young, or belong to a demographic not often featured in studies, you can still develop FD. A diagnosis depends primarily on the physical pattern on the scalp, your symptoms, and specialized examinations rather than your demographic profile.

Common questions in this guide

How common is Quinquaud folliculitis decalvans?
Quinquaud folliculitis decalvans is rare, and its exact frequency in the general population is unknown. Studies from specialist clinics find that it represents a small share of hair-loss cases, but those percentages do not show an individual’s chance of developing it.
Who is most likely to develop folliculitis decalvans?
Anyone can develop folliculitis decalvans. Larger specialist studies have included more men than women, and patients are often in their 30s or 40s when evaluated, but these patterns do not determine who can develop the condition.
Can women or younger people get folliculitis decalvans?
Yes. Women can develop folliculitis decalvans, and cases beginning in childhood or early youth have been reported. Age and sex cannot confirm or rule out the condition.
Is folliculitis decalvans more common in certain ethnic groups or countries?
No strong ethnic or geographic pattern has been established. The condition has been reported in diverse populations worldwide, but differences in access to specialist clinics and referral patterns make comparisons difficult.
How is folliculitis decalvans diagnosed if demographics are not enough?
Diagnosis depends mainly on the scalp pattern, symptoms, and a clinician’s examination rather than age, sex, or ethnicity. A close scalp examination, magnified viewing, and sometimes a small scalp biopsy may help confirm the condition and distinguish it from other causes of scarring hair loss.

Get notified when new evidence is published on Quinquaud folliculitis decalvans.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (14)
  1. 1

    Primary cicatricial alopecia in a single-race Asian population: A 10-year nationwide population-based study in South Korea.

    Yoon J, Choi JW

    The Journal of dermatology 2018; (45(11)):1306-1311 doi:10.1111/1346-8138.14625.

    PMID: 30188582
  2. 2

    Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study.

    Vañó-Galván S, Saceda-Corralo D, Blume-Peytavi U, et al.

    Skin appendage disorders 2019; (5(5)):309-315 doi:10.1159/000496708.

    PMID: 31559256
  3. 3

    Folliculitis decalvans: a multicentre review of 82 patients.

    Vañó-Galván S, Molina-Ruiz AM, Fernández-Crehuet P, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(9)):1750-7 doi:10.1111/jdv.12993.

    PMID: 25682915
  4. 4

    Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.

    Miguel-Gómez L, Rodrigues-Barata AR, Molina-Ruiz A, et al.

    Journal of the American Academy of Dermatology 2018; (79(5)):878-883 doi:10.1016/j.jaad.2018.05.1240.

    PMID: 29864465
  5. 5

    Acquired Alopecias in Mexican Adults: A Clinical and Epidemiological Study of 1,888 Patients.

    Ramírez-Sánchez JA, Vazquez-Cantu DL, Rodriguez-Castellanos MA, et al.

    Cureus 2026; (18(1)):e101165 doi:10.7759/cureus.101165.

    PMID: 41664781
  6. 6

    [Scalp disorders in black Africans treated in a dermatology department in Cotonou (Benin): age-sex-specific epidemiological and clinical features].

    Dégboé B, Koudoukpo C, Habib A, et al.

    The Pan African medical journal 2020; (37()):303 doi:10.11604/pamj.2020.37.303.20997.

    PMID: 33654522
  7. 7

    Changing spectrum of hair and scalp disorders over the last decade in a tertiary medical centre.

    Lyakhovitsky A, Tzanani I, Gilboa S, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2023; (37(1)):184-193 doi:10.1111/jdv.18570.

    PMID: 36066315
  8. 8

    Frequency of Types of Alopecia in a Single-centre Hair Referral Clinic Over a Ten Years Period.

    Uribe NC, Casañas-Quintana E, Trüeb RM

    International journal of trichology 2025; (17(1)):20-24 doi:10.4103/ijt.ijt_57_24.

    PMID: 40654548
  9. 9

    Clinical features of 109 patients with primary cicatricial alopecia: a 15-year retrospective study.

    Zorlu Ö, Albayrak H, Aytekin S

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2026; (35(1)):23-30.

    PMID: 41915583
  10. 10

    Epidemiological, Clinical, and Therapeutic Insights into Folliculitis Decalvans in Skin of Color: A Retrospective Descriptive Study of 17 Cases.

    Loubaris Z, Taib HE, Benzekri L, Meziane M

    Skin appendage disorders 2025; (11(6)):482-487 doi:10.1159/000546565.

    PMID: 40584732
  11. 11

    Comprehensive Case Report on Folliculitis Decalvans in a Pediatric Patient.

    Motsios D, Sotiropoulou K, Karabarba S, et al.

    Acta dermatovenerologica Croatica : ADC 2025; (33(4)):178-181.

    PMID: 42370657
  12. 12

    Histopathologic Spectrum of Alopecias Seen in a Jamaican Setting.

    Ho JD, Collie CJ, Spencer SA

    The American Journal of dermatopathology 2023; (45(8)):532-538 doi:10.1097/DAD.0000000000002487.

    PMID: 37377278
  13. 13

    Primary scarring alopecia: A retrospective study of 89 patients in Taiwan.

    Su HJ, Cheng AY, Liu CH, et al.

    The Journal of dermatology 2018; (45(4)):450-455 doi:10.1111/1346-8138.14217.

    PMID: 29341216
  14. 14

    Navigating Treatments in Folliculitis Decalvans: A Comprehensive Systematic Review.

    Al-Naesan I, Trafoier T, Krepper D, et al.

    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 2026; doi:10.1111/ddg.70607.

    PMID: 42750403

This page is for informational purposes only and does not constitute medical advice. Clinic-based statistics about Quinquaud folliculitis decalvans cannot diagnose or rule out the condition; consult a dermatologist about your symptoms.